Skip to main content
. 2016 Dec 23;48(1):145–151. doi: 10.1161/STROKEAHA.116.014250

Figure 2.

Figure 2.

Outcome on the extended Glasgow outcome score (GOSE) at day 90. Numbers are number of subjects with favorable outcomes (GOSE of 6–8) for each cohort (n=9) and enteral nimodipine (n=18). For each dose cohort of EG-1962 compared with enteral nimodipine, controlling for World Federation of Neurological Surgeons (WFNS) grade and age, the adjusted odds ratio was 1.17 (95% confidence interval [CI] 0.87–1.59; P=0.29).